Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004
- PMID: 17437247
- DOI: 10.1002/pds.1395
Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004
Abstract
Purpose: Understanding the completeness and accuracy of U.S. military anthrax vaccination data is important to the design and interpretation of studies to assess the safety of anthrax vaccine. We estimated the agreement between electronically recorded anthrax vaccination data in the Defense Medical Surveillance System (DMSS) versus anthrax vaccination data abstracted from hardcopy medical charts in a representative sample of the U.S. military from 1998 to 2004.
Methods: Medical chart abstractions were conducted at 28 military treatment facilities for 4201 personnel. Abstracted anthrax vaccination data for 1817 personnel, representing 7400 anthrax vaccine doses, were compared with electronically captured data in the DMSS from 1998 to 2004. Sensitivity, positive predictive value (PPV), specificity and negative predictive value (NPV) were calculated using weighted analyses.
Results: Weighted person-level analysis revealed DMSS sensitivity = 93.8% (95%CI = 91.1, 95.8), specificity = 87.0% (79.0, 92.3), PPV = 85.6% (77.2, 91.3) and NPV = 94.5% (91.7, 96.4). Report of anthrax vaccination within a +/-7 days window in both medical chart and DMSS electronic data had a sensitivity of 88.3% (85.4, 90.7) and a PPV of 86.6% (84.9, 88.2) in the vaccine dose-level analysis.
Conclusions: These results support that anthrax vaccination data captured by the DMSS are adequate for post-marketing surveillance investigations in the U.S. military and are of comparable quality to data captured by other vaccine safety databases.
Copyright (c) 2007 John Wiley & Sons, Ltd.
Comment in
-
Optic neuritis and vaccination investigation: failure to consider significant sex differences and multiple vaccine combinations.Arch Neurol. 2007 Nov;64(11):1673-4; discussion 1674-5. doi: 10.1001/archneur.64.11.1673. Arch Neurol. 2007. PMID: 17998455 No abstract available.
Similar articles
-
A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System.Vaccine. 2007 Apr 30;25(17):3428-36. doi: 10.1016/j.vaccine.2006.12.044. Epub 2007 Jan 26. Vaccine. 2007. PMID: 17258846
-
Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004.Vaccine. 2008 Mar 17;26(12):1577-84. doi: 10.1016/j.vaccine.2008.01.003. Epub 2008 Jan 22. Vaccine. 2008. PMID: 18295379
-
Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.Arch Neurol. 2006 Jun;63(6):871-5. doi: 10.1001/archneur.63.6.871. Arch Neurol. 2006. PMID: 16769869
-
Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. doi: 10.1002/pds.712. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051118 Review.
-
Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. doi: 10.1002/pds.936. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386719 Review.
Cited by 2 articles
-
Vaccination and risk of lone atrial fibrillation in the active component United States military.Hum Vaccin Immunother. 2019;15(3):669-676. doi: 10.1080/21645515.2018.1549453. Epub 2019 Jan 8. Hum Vaccin Immunother. 2019. PMID: 30444675 Free PMC article.
-
Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine.J Infect Dis. 2009 Feb 1;199(3):326-35. doi: 10.1086/596066. J Infect Dis. 2009. PMID: 19099487 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical